Home
Inbox
Search
Speaker
Daniel Wachtlin
MSc
Boehringer Ingelheim Pharma GmbH & Co. KG
Bookmark
Session(s)
Investigating the Effect of Nintedanib on Changes in Biomarkers of ECM Turnover in Patient...
Sunday, May 20
11:15 AM - 1:00 PM
Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF)...
Sunday, May 20
11:15 AM - 1:00 PM
Home
Inbox
Search